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Abstract
Adenovirus 5 (Ad-5) infection is a common cause of acute respiratory infections and the main vector used in gene therapy. 
There are few studies on the relationship of Ad-5 to obesity. In the present study, we evaluated the chronic effects of Ad-5 
infection on golden (Syrian) hamsters fed either a balanced diet (BD) or a high-fat diet (HFD). After a single inoculation 
with Ad-5 (1 ×  107 pfu), the body weight of the animals was measured weekly. Medium-term (22 weeks) serum biochemical 
analyses and long-term (44 weeks) liver morphology, adiposity, and locomotive functionality (movement velocity) assess-
ments were carried out. In the animals fed the BD, adenovirus infection produced hyperglycemia and hyperlipidemia. In 
the long term, it produced a 57% increase in epididymal pad fat and a 30% body weight gain compared with uninoculated 
animals. In addition, morphological changes related to non-alcoholic fatty liver disease (NAFLD) were observed. The animals 
fed the HFD had similar but more severe changes. In addition, the hamsters presented an obesity paradox: at the end of the 
study, the animals that had the most morphological and functional changes (significantly reduced movement velocity) had 
the lowest body weight. Despite the fact that an HFD appears to be a more harmful factor in the long term than adenovirus 
infection alone, infection could increase the severity of harmful effects in individuals with an HFD. Epidemiological stud-
ies are needed to evaluate the effect of adenovirus as a precursor of chronic liver and cardiovascular diseases, including the 
chronic effects of gene therapy.
Introduction
Obesity is a chronic disease characterized by excessive storage 
of adipose tissue in the organism. Its multifactorial etiology 
includes genetic, social, metabolic, endocrine, and neurologi-
cal factors [1]. An infectious origin of obesity has been sug-
gested, due to its rapid dissemination pattern [2]. The concept 
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of virus-induced obesity is not new. Recent studies have sug-
gested that adenovirus types 31, 36, and 37 can infect adipo-
cytes and alter expression patterns, causing triglyceride accu-
mulation, pre-adipocyte differentiation into mature adipocytes 
[3, 4], and increased glucose entry into cells [5, 6].
Most studies relating adenoviruses to obesity have been 
carried out with Ad-36, and there is no longer any doubt 
that it is adipogenic [3]. However, very little research has 
been conducted on type 9 or type 5 adenoviruses. So et al. 
reported that mice inoculated with adenovirus type 5 (Ad-5), 
whose food intake was not different from that of controls, 
had significant weight gain [7]. An epidemiological study 
associated Ad-5 seropositivity with a greater prevalence of 
obesity in children [8].
Epidemiological studies have demonstrated that Ad-5 is 
a very common virus in humans. Five to ten percent of all 
febrile illnesses in infants and young children are attributable 
to adenovirus infections, typically involving the respiratory 
tract and commonly caused by type 5 [9]. Studies carried 
out on different adult populations have shown a prevalence 
of anti-Ad-5 serum antibodies of 57% in the United States 
[10], 74% in the Netherlands [11], 77% in China [12, 13], 
79% in South Africa, and 84% in Gambia [14]. Therefore, it 
is important to determine the long-term changes that Ad-5 
infection can produce with respect to adipogenesis, metabo-
lism, organ morphology, and the general health status of the 
individual.
The majority of in vivo trials on the effects of adenoviral 
infection have been performed on rats or mice. However, 
they are not the ideal rodent models for studying adenovi-
rus infection, given that there can be no viral lytic cycle in 
their cells. Syrian (golden) hamsters (Mesocricetus auratus) 
have been shown to be more appropriate rodents for studying 
adenovirus infection because the virus can replicate in the 
liver, lungs, and most other organs [15–18]. The production 
of adenovirus infections in Syrian hamsters has been dem-
onstrated through intravenous or intranasal inoculation [18], 
as well as via intraperitoneal inoculation [19, 20]. Syrian 
hamsters are also suitable models for studying obesity and 
dyslipidemia [12, 21, 22].
The present study was designed to evaluate the adipo-
genic effect and long-term biochemical, morphological, 
and functional disorders caused by Ad-5 infection in Syrian 
(golden) hamsters fed either a balanced diet or a high-fat 
diet.
Materials and methods
Cells and viruses
Human embryonic kidney (HEK)-293T cells were used 
(Thermo Fisher Scientific, Inc., Waltham, MA, USA). They 
were maintained in DMEM containing 10% fetal bovine 
serum (FBS) and supplemented with L-glutamine, penicil-
lin, and streptomycin (Gibco; Thermo Fisher Scientific, Inc., 
Waltham, MA, USA) at 37°C and 5%  CO2 in a humidified 
environment. Wild-type adenovirus type 5 (Ad5) was used. 
Viruses were grown on HEK-293 cells and purified using a 
ViraKit AdenoMini-24 kit (Virapur LLC, San Diego CA, 
USA) according to the manufacturer’s instructions [23]. 
The viruses were titrated on HEK-293 cells by tissue cul-
ture infectivity dose 50  (TCID50) as described previously in 
the Vector System Application Manual, version 1.4 (Virapur 
LLC, San Diego CA, USA).
Animals and study design
Female rodents, including hamsters, produce hormones that 
promote an increase in fat storage and body weight gain 
[24, 25]. To control the influence of that natural hormo-
nal adipogenic factor on the present experiment, only male 
animals were selected. In addition, the hepatic lipoprotein 
metabolism of the male hamster has been found to closely 
resemble that of humans [26, 27]. The present study was 
therefore carried out using 40 male Syrian (golden) ham-
sters (HsdHan™:AURA; Envigo, Huntingdon, UK) (6-8 
weeks old). They were handled under sterile conditions and 
kept in cages with filters to avoid contact with microorgan-
isms. Conditions were controlled (12 h:12 h light/dark cycle, 
23°C temperature with 50% humidity), and water was freely 
available. National and international norms for laboratory 
animal care were followed. Before the study was begun, the 
hamsters were acclimated to the animal laboratory environ-
ment for 15 days. Twenty animals were fed a high-fat West-
ern diet (HFD) that contained 21.2% fat and 17.3% protein 
(TD.02028 Atherogenic Rodent Diet, Envigo, Huntingdon, 
UK), and 20 were fed a balanced rodent diet (BD) that con-
tained 6.2% fat and 18.6% protein (2018S Tekland Global 
18% Protein Rodent Diet, Envigo, Huntingdon, UK). Half 
of the animals from each dietary group were inoculated 
with a single application of adenovirus type 5, forming 
four groups for the experiment: two groups fed the BD (one 
group infected with Ad-5 and the other not infected with 
Ad-5, as the control) and two groups fed the HFD (one group 
infected with Ad-5 and the other not infected with Ad-5, 
as the control). The placement of animals in the different 
groups was random.
For adenovirus type 5 inoculation (infected groups), 1 
×  107 infectious Ad-5 viral particles (pfu) were dissolved 
in 100 µl of DMEM and administered intraperitoneally. 
Physiological saline solution was administered to the control 
groups. The experimental animals were monitored through 
direct observation, at least once during the first 30 min-
utes, periodically during the first 24 hours, and then at least 
once a day to qualitatively detect any adverse clinical signs, 
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following the guidelines of the Organisation for Economic 
Co-operation and Development [28, 29]. The adverse clini-
cal signs detected in the acute infection phase are described 
in the Results and Discussion sections. One venous blood 
sample was drawn from the animals at post-inoculation day 
3 and week 6. DNA was isolated from those samples by the 
standard method (proteinase K treatment, phenol/chloroform 
extraction, and ethanol precipitation) [30]. The presence of 
adenovirus was determined from that DNA through real-
time PCR, using a TaqMan assay, with oligonucleotides and 
a probe designed for the adenoviral E1A terminal region as 
described previously [31]. Animal body weight was deter-
mined every week for 44 weeks. At week 22 of that period, 
the medium-term effect was assessed through measurements 
of body weight, serum cholesterol, high-density lipoprotein 
(HDL), albumin, globulin, and glucose (with 4 h of fast-
ing). Non-HDL cholesterol was computed as the difference 
between total cholesterol and HDL cholesterol [22]. Those 
biochemical analyses were performed in triplicate using 
an automatic biochemical analyzer (Cobas c111, Roche ®, 
Mexico). The long-term effect (follow-up at week 44) was 
analyzed through body weight measurement and locomo-
tor activity evaluation. The animals were then euthanized 
by decapitation, their epididymal fat pads and livers were 
weighed, and histopathologic liver analysis was carried out. 
The epididymal fat pad is very well delineated in hamsters 
and has been used as a parameter for determining alterations 
in fat accumulation in animals (the adipogenic effect, when 
an increase in fat is found) [32].
The hamsters were observed for 44 weeks. Taking into 
account the age of the animals upon their entrance into the 
study, the final analyses were carried out on animals that 
were 52-54 weeks old. Three factors were considered for 
selecting that period of observation: 1) under normal labora-
tory conditions, animals gain their maximum weight at 20 to 
30 weeks [21, 33–35]; 2) changes in animal behavior related 
to the aging process begin at 50 weeks of life [36]; and 3) 
animal death has been reported to start a little after week 
50 and can begin even sooner if the animals are exposed to 
damaging factors, such as cigarette smoke [37]. Therefore, 
the length of time the animals were followed in the present 
study made it possible to observe them from the stages of 
youth to old age without entering the accelerated mortality 
stage.
Locomotor activity evaluation
At week 44, the locomotor activity of the hamsters was 
evaluated through an open field activity monitoring system, 
which is a useful tool for assessing locomotive impairment 
in animal models utilizing small rodents, including hamsters 
[38–42]. For that trial, a cube with 55 × 55 cm acrylic walls 
was used as the open field. Each hamster was placed in the 
center of the cube and allowed free exploration for 5 min. 
When that time was up, the animal was removed from the 
cube and returned to its box. The session was videotaped 
and evaluated using EthoVision XT7 video tracking soft-
ware (Noldus Information Technology, Inc. Leesburg, VA, 
USA), thus determining the motional velocity of the hamster 
(cm/s). After each trial, the instrument was cleaned to return 
to standard conditions [43]. A significant change in velocity, 
compared with a control, was considered an alteration in the 
locomotor activity of the experimental animal [44].
Histopathologic liver analysis
Liver tissues were fixed in solutions of 10% formaldehyde 
for 5 days at 24°C. Two cross-sectional slices were made 
from the right lobe (the central region and external third 
region), and one slice was made from the left lobe. The 
specimens were dehydrated in ethanol, embedded in paraffin 
wax, sectioned (5-µm thick), and stained with hematoxylin 
and eosin at 24°C for 5 and 2 min, respectively. Glycogen 
storage was observed through periodic acid-Schiff staining 
(PAS). The tissue slices were placed in the Schiff reagent 
for 15 min, rinsed in water for 10 min, and counterstained 
with Mayer’s hematoxylin for 1 min. The slices were evalu-
ated via images captured with an Axiocam MRC-5 model 
digital camera (Zeiss GmbH, Jena, Germany) attached to an 
AxioPlan 2 M model bright-field optical microscope (Zeiss 
GmbH, Jena, Germany) with a motorized stage and A-plan 
x20 objective. Images (200X) of the entire surfaces of the 
samples were assembled using the MosaiX and Autofocus 
modules. All images were captured under the same condi-
tions of light and exposure. The same blinded pathologist 
performed the analyses using AxioVision software version 
4.0 (Zeiss GmbH, Jena, Germany) [45, 46].
Binucleated cells were identified in the images of the 
entire surfaces of the liver samples (stained with hematoxy-
lin/eosin), and their percentage in relation to the total num-
ber of cells was calculated. The number of cells per square 
millimeter was also determined. The areas with degenera-
tive data were manually marked in the interactive mode to 
calculate the percentage of the area with liver degeneration. 
The percentage of the area with glycogen was calculated in 
a similar manner, but also included the measurement of the 
areas stained with PAS.
Steatosis was considered in relation to the percentage of 
liver tissue with fat accumulation [47]. According to pre-
viously described methodology and classification, inflam-
mation was evaluated through the functioning histologic 
zones, depending on the oxygen supply: zone 1 encom-
passed the portal tracts, where the oxygenated blood from 
the hepatic arteries entered; zone 3 was located around the 
central veins, where oxygenation was poor; and zone 2 was 
located between zones 1 and 3. There were four categories 
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in relation to the percentage of tissue with inflammatory 
infiltrate: none, mild, moderate, and severe (0%, up to 33%, 
33-66%, and more than 66%, respectively) [48]. The histo-
pathologic analyses were performed on the digital images of 
the entire surface of each liver sample (right and left lobules) 
at a magnification of X200, with 3000 to 6000 individual 
fields merged into one panoramic image. The pathologic 
changes were quantified per area and compared accordingly.
Statistical analysis
Mean and standard deviation were used for the descriptive 
statistics. For the inferential statistics, normal data distribu-
tion was first determined through the Kolmogorov-Smirnov 
test, and the equality of variances was confirmed using Lev-
ene’s test. One-way ANOVA was used to analyze differences 
between groups. A further in-depth post-hoc analysis of the 
variation was carried out using Student’s t-test, which ena-
bled the differences between each of the groups to be deter-
mined. Statistical tests were performed using IBM SPSS 
version 20 software (IBM SPSS, Chicago, Illinois, USA). 
Statistical significance was set at P < 0.05.
Bioethical issues
The trials complied with the national and international legal 
and ethical requirements applicable to pre-clinical research. 
The experimental protocols were approved by the Research 
Ethics Committee of the School of Medicine of the Univer-
sidad de Colima, Mexico (Protocol Number: UCOL14-016). 
The animals were handled according to institutional guide-
lines, the Mexican official norm regulating laboratory animal 
use (NOM-062-ZOO-1999), and the Guide for the Care and 
Use of Laboratory Animals issued by the National Acad-
emy of Sciences of the United States of America (2011). All 
animals were euthanized (by decapitation) according to the 
American Veterinary Medical Association (AVMA) Guide-
lines for the Euthanasia of Animals: 2013 Edition.
Results
Ad‑5 infection in hamsters
The presence of adenovirus particles in blood was confirmed 
by real-time PCR on the third day after inoculation with 
Ad-5. The animals inoculated with the virus were positive 
for Ad-5, and those of the control groups (not inoculated 
with Ad-5) were negative. At post-inoculation week 6, all 
of the animals (infected and controls) were negative for the 
presence of adenoviral DNA in blood samples, determined 
through real-time PCR, demonstrating that the infection 
was self-limited and acute. Adynamia was observed in the 
infected group the day after Ad-5 inoculation. Diaphoresis, 
chills, and reduced food intake were observed on days 2 and 
3. Signs reverted on days 4 and 5, except adynamia. Ady-
namia disappeared between days 6 and 7, and the animals 
regained a “normal” aspect (the same as that of the non-
infected hamsters). There were no alterations in aspect or 
behavior in the group inoculated with saline solution.
Body weight gain: short‑term, medium‑term, 
and long‑term effects
As shown in Figure 1A, no differences in mean weight were 
observed in the groups fed the balanced diet from the begin-
ning of the study. However, beginning at week 8 and contin-
uing to the end of the study, the body weight of the infected 
animals was significantly higher than the body weight of the 
control-group animals. At the medium-term (weeks 8-22), 
the body weight of the Ad-5-infected animals was on aver-
age 4 to 6% higher than that of the control-group animals (P 
< 0.05). The long-term effect (at week 44) was striking, with 
the body weight of the Ad-5-infected animals being 30% 
higher than that of the non-infected animals (P < 0.0001; 
see Fig. 1A and the Electronic Supplementary Material for 
further details).
There was rapid weight gain in the animals fed the high-
fat diet during the first weeks. From week 3 to week 16, 
the body weight of the uninfected animals fed the high-fat 
diet was significantly higher than that of the animals fed the 
balanced diet (P < 0.05). From week 22, all of the groups, 
except the adenovirus-infected group fed a balanced diet, 
began to gradually lose weight. This weight loss was more 
accelerated in the animals fed the high-fat diet. Thus, from 
week 22, the body weight of the animals fed the high-fat diet 
was significantly lower than that of the animals fed the bal-
anced diet (P < 0.05; see Electronic Supplementary Material 
for further details). No significant changes were observed 
between the infected and uninfected animals fed the high-
fat diet, except at weeks 22 (P = 0.003) and 36 (P = 0.04), 
in which the infected animals had an approximately 10% 
higher body weight than the animals in the uninfected group 
(see Fig. 1B and Electronic Supplementary Material). No 
significant differences in body weight were observed in the 
long term at 44 weeks between the infected and uninfected 
animals fed the high-fat diet (see Fig. 1B and Electronic 
Supplementary Material for further details).
Serum biochemical parameter alterations: 
medium‑term effects
In the medium term at week 22, metabolic changes caused 
by Ad-5 infection were observed. Acute Ad-5 infection in 
the animals fed the balanced diet caused significant eleva-
tion in globulin, glucose, total cholesterol, and non-HDL 
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cholesterol levels, together with a reduction in HDL choles-
terol levels, compared with the uninfected control group ani-
mals (Table 1). Acute Ad-5 infection in the animals fed the 
high-fat diet caused no relevant changes in the parameters 
studied, except elevated total cholesterol levels. It should 
be pointed out that the high-fat diet itself caused significant 
changes in all of the study parameters when compared with 
the animals fed the balanced diet (Table 1).
Long‑term effects: epididymal fat pad weight gain
The epididymal fat pads of male rodents are frequently sam-
pled because they are often used as a proxy of visceral fat 
[49] and adipogenesis [50]. The epididymal fat pad bulk 
mass at week 44 is shown in Fig. 2A. In the animals fed the 
balanced diet, epididymal fat pad weight was 57% higher in 
the animals infected with Ad-5 than in the uninfected con-
trols (P = 0.0002). No significant differences were observed 
between the infected and uninfected animals fed the high-
fat diet (P = 0.20). Comparisons between the animals fed 
a balanced diet and those fed a high-fat diet are shown in 
Electronic Supplementary Material.
Long‑term effects: locomotion function
The movement velocity of the animals in an open field was 
determined. As shown in Fig. 2, no significant differences 
were observed between the infected and uninfected animals 
that were fed the balanced diet (8.0 ± 2.3 vs. 9.6 ± 2.9 cm/s, 
respectively). However, in the animals fed the high-fat diet, 
those infected with Ad-5 had significantly lower movement 
velocity than the uninfected animals (6.1 ± 0.6 vs. 9.4 ± 2.4 
cm/s, P < 0.05) (Fig. 2C).
Long‑term effects: liver morphology
Figure 2B shows the hamster liver weight. The livers of the 
infected animals fed the balanced diet weighed 22% more 
than those of the uninfected animals of the control group 
(P = 0.001). No significant differences in liver weight were 
observed between the infected and uninfected animals in the 
high-fat diet groups (P = 0.56). It is important to mention 
that the livers of the animals fed the high-fat diet weighed 
significantly more than the livers of the animals fed the bal-
anced diet (uninfected control groups: 7.8 ± 1.0 vs. 5.4 ± 
0.4 grams, P = 0.0002; infected groups: 8.2 + 0.7 vs. 6.7 ± 
0.8 grams, P = 0.001, in the animals fed the high-fat diet vs. 
those fed a balanced diet, respectively). In the comparison 
of liver weights of the animals exposed to a single risk factor 
(Ad-5 infection or high-fat diet), the livers of the uninfected 
animals fed a high-fat diet weighed more than the livers 
of the Ad-5-infected animals fed the balanced diet (7.8 ± 
1.0 vs. 6.7 ± 0.8 grams, respectively; P = 0.004). Those 
results showed greater hepatomegaly caused by the high-fat 
diet than by Ad-5 infection, making it clear that diet was 
more relevant than infection in relation to long-term liver 
alterations.
No steatosis was present in the liver tissues analyzed by 
microscopy. All of the livers of both the infected and unin-
fected animals fed the high-fat diet had mild inflammation, 
whereas the livers of the animals fed the balanced diet had 
no signs of inflammation. Table 2 shows that there were 
no significant differences in the number of hepatocytes per 
square millimeter between the Ad-5-infected animals and 
the uninfected controls. Thus, it can be assumed that the 
increased liver weight in the infected animals was due to 
an increase in the total number of cells (hyperplasia) and 
Fig. 1  Body weight of the animals fed the balanced diet (A) and the 
high-fat diet (B). The Ad-5-infected animals fed the balanced diet 
had significant and continuous weight gain from week 8, with a 30% 
increase at the end of the study, with respect to the controls. The Ad-
5-infected animals fed the high-fat diet had significant weight gain 
only at weeks 22 and 36. Reduced body weight was observed in most 
of the animals, regardless of group. A similar event has been reported 
within the life cycle of Syrian hamsters (see Discussion). Mean and 
standard deviation are plotted. *, P < 0.05
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not to an increase in cell size. The Ad-5-infected hamsters 
fed the balanced diet had an increase in the percentage of 
binucleated cells and a reduced glycogen area relative to the 
uninfected hamsters (Fig. 3). In the animals fed the high-fat 
diet, those infected with Ad-5 had a reduced glycogen area 
and an increased percentage of the area with liver degen-
eration compared with the uninfected animals (Table 2 and 
Fig. 3). These data show that Ad-5 infection caused chronic 
liver changes when compared with the animals that were 
not infected, regardless of diet. Nevertheless, the Ad-5-in-
fected animals fed the high-fat diet had the most substantial 
changes in microscopic liver morphology.
Compared with the animals fed the balanced diet, the ani-
mals fed the high-fat diet had an increase in the number of 
hepatocytes per square millimeter and in the percentage of 
binucleated cells, as well as a reduction in the area occupied 
by glycogen. These changes occurred in both the infected 
and uninfected animals. In a comparison of hyperplasia and 
the increase in binucleated cells in the livers of the animals 
exposed to only one risk factor (Ad-5 infection or high-fat 
diet), we found that the livers of the uninfected animals 
fed the high-fat diet had higher values in both parameters 
than the Ad-5-infected animals fed a balanced diet. Greater 
hyperplasia and hepatocyte binucleation were caused by the 
high-fat diet rather than by Ad-5 infection, suggesting that 
diet is more relevant than infection in relation to long-term 
microscopic liver alterations (Table 2).
Discussion
It was possible to determine that a single and transitory 
infection with adenovirus type 5 was capable of promot-
ing significant weight gain in hamsters fed a balanced diet. 
In the long term, the animals with Ad-5 infection had a 
Table 1  Comparison of different biochemical parameters according 
to type of diet and Ad-5 exposure at week 22 of follow-up (medium-
term effect)
The values are expressed as mean ± SD (mg/dL or *g/dL). HDL, 
high-density lipoprotein cholesterol; nHDL-C, non-HDL cholesterol. 
Statistical analysis was carried out using Student’s t-test
**Comparison of balanced diet vs. high-fat diet groups
***Comparison of uninfected vs. infected groups
Parameters per group Diet P**
Standard High-fat
Glucose
 Control 79.6 ± 20.8 92.5 ± 19.4 0.040
 Infected 107 ± 17.1 101.7 ± 21.5 0.250
 P*** 0.004 0.35
Cholesterol
 Control 91 ± 3.1 226.3 ± 61.7 <0.001
 Infected 90.5 ± 1.5 273.5 ± 47.5 <0.001
 P*** 0.640 0.04
HDL-C
 Control 32 ± 11.9 112.1 ± 51.3 <0.001
 Infected 18.7 ± 10.6 148.8 ± 76.3 <0.001
 P*** 0.009 0.140
nHDL-C
 Control 59.0 ± 10.2 114.0 ± 53.7 <0.001
 Infected 71.8 ± 8.8 124.0 ± 53.5 0.003
 P*** 0.005 0.310
Albumin*
 Control 2.52 ± 0.23 1.95 ± 0.31 0.001
 Infected 2.65 ± 0.19 2.10 ± 0.32 <0.001
 P*** 0.100 0.210
Globulin*
 Control 3.58 ± 0.41 4.90 ± 0.36 <0.001
 Infected 3.89 ± 0.30 4.60 ± 0.43 <0.001
 P*** 0.024 0.101
Fig. 2  Epididymal fat pad weight (A), liver weight (B), and move-
ment velocity of the animals (C) in the long term (week 44). There 
was a significant increase in the weight of the epididymal fat pads and 
livers of the Ad-5-infected animals fed the balanced diet relative to 
the uninfected controls. There were no differences in the weights of 
these organs in the animals fed the high-fat diet. Regarding the move-
ment velocity (cm/s) of the animals (C), only the Ad-5-infected ani-
mals fed the high-fat diet had significantly lower motional velocity 
when compared with the other groups. Mean and standard deviation 
are plotted. *, P < 0.05
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30% higher body weight and a 57% higher accumulation 
of epididymal pad fat. In addition, Ad-5 exposure caused 
metabolic changes in the medium term (week 22), with 
clear hyperglycemia and hyperlipidemia. In the long term 
(week 44), hyperplasia, increased binucleation, and an 
increased nuclear area at the hepatic level were observed 
in the animals with Ad-5 infection fed a balanced diet, as 
well as a decreased percentage of liver tissue with glycogen. 
Binucleation (polyploidization) is one of the most dramatic 
changes that can occur in the genome [51–53]. In the liver, 
physiological polyploidization events occur both during liver 
development and throughout adult life [51–53]. However, 
pathological polyploidization is known to take place in the 
early stages of nonalcoholic fatty liver disease (NAFLD), 
which is promoted by an increase in oxidative stress [51–53]. 
Liver hyperplasia has also been confirmed in the earliest 
stage of NAFLD in ob/ob mice, identifying this characteris-
tic as an obesity-related metabolic abnormality [54]. In addi-
tion, reduced hepatic glycogen is a characteristic that has 
previously been associated with chronic liver damage [55].
Obesity, hyperlipidemia, hyperglycemia, and chronic 
liver damage (NAFLD) are systemic disease mediators that 
are associated with increased liver-related complications 
and liver-related mortality, as well as an increased risk for 
developing type 2 diabetes, cardiovascular disease (CVD), 
chronic kidney disease, and certain malignancies, including 
primary liver cancer and colorectal cancer [56–59]. Thus, 
the results of the present study are relevant, because in addi-
tion to showing the obesogenic effect of Ad-5 infection in 
Table 2  Comparison of the different histological parameters accord-
ing to type of diet and Ad-5 exposure at week 44 of follow-up (long-
term effect)
Statistical analysis was carried out using Student’s t-test
*Comparison of balanced diet vs. high-fat diet groups
**Comparison of uninfected vs. infected groups
Parameters per group Diet
Standard High-fat P*
Hepatocytes/mm2
 Control 2.36 ± 0.30 3.11 ± 0.40 <0.001
 Infected 2.49 ± 0.29 3.31.7 ± 0.31 <0.001
 P** 0.320 0.190
% binucleated cells
 Control 8.6 ± 2.2 15.1.3 ± 4.2 <0.001
 Infected 11.1 ± 2.5 12.1 ± 4.2 0.260
 P** 0.010 0.150
% of nuclear area
 Control 16.0 ± 2.5 30.5 ± 1.6 0.003
 Infected 30.8 ± 2.1 30.2 ± 2.9 0.330
 P** 0.006 0.420
% of area with glycogen
 Control 20.1 ± 8.6 3.9 ± 2.7 <0.001
 Infected 10.6 ± 3.7 0.9 ± 0.9 <0.001
 P** 0.030 0.040
% of area with degeneration
 Control 16.0 ± 5.6 19.9 ± 6.3 0.100
 Infected 16.5 ± 6.6 40.2 ± 12.5 <0.001
 P** 0.420 0.002
Fig. 3  Images showing the 
liver morphology of uninfected 
animals fed a balanced diet 
(A), Ad-5-infected animals fed 
a balanced diet (B), uninfected 
animals fed a high-fat diet (C), 
and Ad-5-infected animals fed a 
high-fat diet (D). Images show 
periodic acid-Schiff stain-
ing (PAS) x200. The images 
mainly show the changes in 
the glycogen deposits, which 
are bright purple (#a00498 
Color Hex) and indicated by 
yellow arrows. The deposits are 
abundant in panel A, gradu-
ally reduced in panels B and C, 
and extremely scarce in panel 
D. The red arrow indicates 
a binucleated cell (only for 
illustrative, not comparative, 
purposes). The results of the 
analysis of those parameters are 
shown in Table 2. The lower 
glycogen content is apparent 
in the infected animals vs. the 
uninfected animals
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the long term, they also confirmed the induction of meta-
bolic and hepatic morphology alterations that are associated 
with increased morbidity and mortality.
However, human obesity and its associated disorders have 
a multifactorial etiology. Their complexity cannot be fully 
explained by a single factor, such as Ad-5 infection alone, 
and therefore we also analyzed the effect of a high-fat diet 
in the present study. It was obvious that a high-fat diet, on 
its own, caused rapid weight gain in the medium term, with 
hyperglycemia and hyperlipidemia, when compared with a 
balanced diet. It also produced pathologic changes in liver 
morphology in the long term. In animals that were fed a 
high-fat diet, Ad-5 infection caused significant weight gain 
in the medium term (week 22) and resulted in an increase in 
the already higher total cholesterol levels, when compared 
with uninfected control animals that were fed a high-fat 
diet. In the long term (week 44), liver morphology, already 
affected by the high-fat diet, became more deteriorated in 
the animals exposed to Ad-5, and there was a considerable 
reduction in the amount of glycogen and an increase in the 
degenerated areas. Liver degeneration also reflects damage 
previously associated with NAFLD [60]. The significant 
reduction of serum albumin in the animals fed the high-fat 
diet, regardless of Ad-5 infection (Table 1), coincided with 
the greater liver damage found in the HFD groups at the end 
of the study. Reduced albumin levels have previously been 
related to obesity [61, 62] and to NAFLD [63, 64] and are 
an important morbidity indicator in chronic diseases [65, 
66]. In general, our results revealed that both a high-fat diet 
and adenovirus type 5 infection, each on their own, caused 
adverse health events in the long term. Health was damaged 
more in animals with only a high-fat diet than in animals that 
had a balanced diet plus Ad-5 infection, but the most severe 
alterations were found in the group with the combination of 
a high-fat diet and Ad-5 infection.
Hamster motional velocity was significantly reduced only 
in the animals with both Ad-5 infection and a high-fat diet. 
That is a relevant result because it is the first time adenovirus 
infection has been shown to cause functional alterations in 
animals in the long term, even though the alterations were 
only observed when the infection was combined with HFD. 
The authors of a recent study on humans reported that the 
presence of a cardiovascular risk factor burden, especially 
when combined with other factors, may increase the risk of 
walking speed limitation in older adults under 78 years of 
age, independent of cognitive function [67]. In the present 
study, the significant reduction in the movement velocity of 
the animals infected with Ad-5 and fed a high-fat diet could 
represent a greater cardiovascular compromise than in the 
animals of the other study groups.
The body weight loss observed in the animals at the end 
of the study (Fig. 1) could be associated with the life cycle of 
Syrian hamsters, given that they reach their maximum body 
weight at 20 to 30 weeks of age, after which they begin to 
experience gradual weight loss [21, 33–35]. Weight loss was 
greater in the animals fed the high-fat diet, which could be 
the consequence of the deleterious effect on health caused 
by the high-fat diet. Previous studies have shown that weight 
loss in Syrian hamsters towards the end of their lives can be 
greater when the animals are exposed to damaging factors, 
such as cigarette smoke [37, 68]. In addition, we observed 
that the animals fed a high-fat diet had the most severe mor-
phological changes, despite having less accumulation of fat 
(epididymal fat pad) and lower body weight at the end of the 
study. Similar results were reported in previous studies that 
described a paradox in advanced chronic diseases: involun-
tary weight loss could be related to increased mortality,[69, 
70] rather than a protective factor (obesity paradox) [71, 72].
An important aspect of obesity pathophysiology is 
chronic inflammation [73]. The liver tissue of the animals 
fed the HFD showed mild inflammation, with no differences 
between the infected and uninfected animals. In contrast, 
the livers of the animals fed a balanced diet (infected ani-
mals and controls) showed no inflammatory changes. These 
results once again demonstrate that the HFD was capable of 
causing more long-term changes than Ad-5 infection alone. 
Serum globulins were also analyzed. Elevated levels have 
been related to chronic inflammation [74–77] and patholo-
gies that also present with inflammation, such as NAFLD 
[64], advanced liver fibrosis [78], or diabetes [76, 79, 80]. 
Animals that were fed a balanced diet and exposed to Ad-5 
in the present study had significantly high levels of serum 
globulins at follow-up week 22 compared to controls. How-
ever, it is striking that animals that were fed an HFD had 
higher globulin levels than those that were fed a balanced 
diet, regardless of Ad-5 infection (Table 1). This eleva-
tion of the globulin level is most likely associated with a 
chronic inflammatory state [74–77]. Ad-36 has been shown 
to elevate IL-6 production, perhaps contributing to the mild 
chronic inflammation associated with obesity [84]. The lack 
of measurement of specific inflammation markers in serum 
and organs other than the liver is a limitation of the present 
study, and these measurements should be included in future 
investigations.
The supposition that Ad-5 could potentiate the develop-
ment of obesity and chronic liver damage is relevant. Adeno-
virus type 5 is one of the most widely disseminated viruses 
worldwide. It is a common cause of air-borne infections, as 
well as of the “common cold” in humans, being responsible 
for 13% of acute respiratory infections [81]. Therefore, the 
probable association between obesity and adenovirus type 
5 could have great epidemiologic relevance in humans [8]. 
The majority of studies on adenoviruses as a causal agent 
of obesity have been carried out with Ad-36. Today, there 
is no doubt that Ad-9, Ad-31, Ad-36, and Ad-37, and a 
non-human adenovirus, SMAM1, are linked to increased 
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adiposity in vitro or in vivo [1, 3, 4, 82]. The possible role 
of infection by adenovirus type 5 in relation to the pathogen-
esis of obesity has not been extensively studied. In 2005, So 
et al. showed that mice inoculated with Ad-5 had significant 
weight gain at week 21 (21.8 g for inoculated mice vs. 18.8 g 
for control mice) [7]. In addition, an epidemiological study 
associated Ad-5 seropositivity with obesity in children [8].
Multiple mechanisms may condition the pathogenic 
effects that adenoviruses have on obesity progression. The 
adipogenic effect has been observed to be a consequence of 
Ad-36 E4 orf-1 gene expression, because when expression 
of the gene is blocked, the effect disappears [6]. Increased 
adiposity is caused by different mechanisms. One of them 
is the increased expression of peroxisome proliferator-acti-
vated receptor-γ, resulting in the differentiation of adult stem 
cells into adipocytes [4]. Different studies have also shown 
that Ad-36 infection can produce alterations in serum lipids 
[85, 86], including an increase in the activity of fatty acid 
synthase, which converts glucose to fatty acids [4]. Glu-
cose metabolism has also been reported to be altered by 
Ad-36, demonstrating that cell membrane glucose recep-
tors are increased via the Ras pathway, leading to increased 
intracellular glucose [4]. Insulin sensitivity has been found 
to increase, which is being studied in relation to the fight 
against diabetes [83]. However, there have been no previous 
reports of an association between Ad-5 infection and serum 
glucose or lipid elevation, an event that was found in the pre-
sent study. That is an interesting and previously unreported 
observation, possibly reflecting a phenomenon associated 
with significant weight gain caused by Ad-5.
A limitation of the present study was that the affected tis-
sues were not tested for the chronic presence of adenovirus 
DNA or RNA, and no histologic analysis was performed on 
muscle or adipose tissues. Future studies that include those 
aspects will aid in better understanding the pathophysiology 
of the chronic illnesses caused by adenoviruses.
Further epidemiological studies are needed to evaluate 
the long-term effects of infection with Ad-5 and other adeno-
viruses. The present study showed that the effects of Ad-5 
infection went beyond that of simply producing obesity. The 
possible applicability of an anti-adenovirus vaccine (initially 
against Ad-36) to fight obesity has already been suggested 
[87], and we can now also suggest that such a vaccine could 
also prevent or delay severe complications in subjects that 
present with obesity caused by a high-fat diet. The results of 
the present study should also be taken into account in evalu-
ating the long-term effects of gene therapy with adenoviral 
vectors, especially their use in young patients.
In conclusion, Ad-5 infection caused an obesogenic 
effect in the long term, with adverse metabolic, morpho-
logical (hepatic), and functional changes, in an animal 
model. Despite the fact that a high-fat diet appears to be 
more harmful in the long term than adenovirus infection 
alone, infection could increase the severity of harmful effects 
in individuals with that type of diet. Epidemiologic studies 
are needed to evaluate the effect of Ad-5 on the genesis of 
obesity and chronic cardiovascular and liver diseases. The 
results should also be considered in the evaluation of the 
long-term effects of gene therapy with adenoviral vectors.
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